Cannabis use is increasing, especially among adolescents, and among them 20% are considered at risk of problematic use. The motivations for cannabis use range from recreational to therapeutic use, causing a blurred distinction between these two purposes. In addition to the short-term and long-term adverse effects of cannabis, the lack of control of these products exposes consumers to health risks due to substances either in excessive concentrations or simply unwanted (contaminants or voluntary adulteration). Cannabis users represent a very heterogeneous population, with subgroups with different patterns of use.
This population is insufficiently characterized.
The Cannabinoscope project, supported by IRESP (Institute for Public Health
Research), brings together a consortium of 3 partners: UMR 8076 BioCIS (CNRS / Université Paris-Saclay), UMR 1252 SESSTIM (INSERM / IRD / Aix-Marseille University) and RESPADD (Paris). Its objective is to establish a platform for monitoring products in the field, aimed at consumers, which will make it possible to 1) obtain actual data on the quality of products in circulation (either legal or illegal), 2) disseminate a questionnaire on the modalities of use, 3) carry out semi-structured interviews intended to characterize this population in its diversity as well as their motivations and behaviors, and (4) propose an appropriate and effective cannabis-related harm reduction strategy.
Applications are being considered until April 15th, 2023
You will find further information in the job offer.
Academic and research jobs and vacancies in schools of medicine, pharmacy and biomedical sciences.